A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

NCT ID: NCT05394324

Last Updated: 2025-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1674 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-21

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Refractive Error Glaucoma Cataracts Clear Lens Exchange

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention

No study treatments will be administered during this retrospective study. However, data will be collected from medical records of patients who have been treated with subject devices of this study.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who have been implanted with and/or undergone ophthalmic surgery using targeted JJSV products
2. Status post ophthalmic surgery between 1 day and 24 months for Year 1. Subsequent years after Year 1 will be between 1 day and 18 months.

Exclusion Criteria

1. Concurrent participation (during the retrospective follow-up period) in an interventional (drug, device, biologic, etc.) clinical trial
2. Use of surgical devices not in accordance with the product labeling or indications for use
3. Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period
4. Use of systemic or ocular medications that may affect vision during the retrospective data collection period
5. Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period
6. Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johnson & Johnson Surgical Vision, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johnson & Johnson Surgical Vision, Inc. Clinical Trial

Role: STUDY_DIRECTOR

Johnson & Johnson Surgical Vision, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trinity Research Group, LLC

Dothan, Alabama, United States

Site Status

Empire Eye and Laser Center

Bakersfield, California, United States

Site Status

Chu Vision Institute

Bloomington, Minnesota, United States

Site Status

Valley Retina Institute

McAllen, Texas, United States

Site Status

Augenaerzte Gerl & Kollegen MVZ Ahaus GmbH

Ahaus, North Rhine-Westphalia, Germany

Site Status

Augenzentrum Erzgebirge

Zschopau, Saxony, Germany

Site Status

Augentagesklinik Spreebogen Berlin GbR

Berlin, , Germany

Site Status

Clinica Vistahermosa

Alicante, Alacant, Spain

Site Status

Hospital La Arruzafa

Córdoba, Andalusia, Spain

Site Status

Instituto Universitario de Oftalmobiologia Aplicada

Valladolid, CL, Spain

Site Status

Hosp. De La Santa Creu I Sant Pau

Barcelona, CT, Spain

Site Status

Hospital Clinico San Carlos

Madrid, MD, Spain

Site Status

Clinica Oftalvist

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Germany Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JJSV301PMCF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.